about
Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequenceFunctional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycansBinding of Sindbis virus to cell surface heparan sulfateLarge-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulationPassage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein E(rns)Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence.Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assemblyCapillary electrophoresis for the analysis of glycosaminoglycans and glycosaminoglycan-derived oligosaccharides.Heterogeneity of heparan sulfates in human lung.Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry.Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model.CS lyases: structure, activity, and applications in analysis and the treatment of diseasesKinetic and structural studies on interactions between heparin or heparan sulfate and proteins of the hedgehog signaling pathway.Ability of the Encephalitic Arbovirus Semliki Forest Virus To Cross the Blood-Brain Barrier Is Determined by the Charge of the E2 GlycoproteinGlypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis.Recent progress and applications in glycosaminoglycan and heparin research.Collagen and glycosaminoglycan profiles in the canine cervix during different stages of the estrous cycle and in open- and closed-cervix pyometraCellular adhesion responses to the heparin-binding (HepII) domain of fibronectin require heparan sulfate with specific properties.Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate.Different evolutionary patterns of classical swine fever virus envelope proteins.Multiple heparan sulfate chains are required for optimal syndecan-1 function.A catalytic role of heparin within the extracellular matrix.Heparan sulfate separation, sequencing, and isomeric differentiation: ion mobility spectrometry reveals specific iduronic and glucuronic acid-containing hexasaccharides.Collagen-glycosaminoglycan matrix implantation promotes angiogenesis following surgical brain trauma.Sterically blocking adhesion of cells to biological surfaces with a surface-active copolymer containing poly(ethylene glycol) and phenylboronic acid.Characterization of polyurethane scaffold surface functionalization with diamines and heparin.Heparan sulfate/heparin (HS-GAG) metabolismHS-GAG biosynthesisElectrostatic Forces as Dominant Interactions Between Proteins and Polyanions: an ESI MS Study of Fibroblast Growth Factor Binding to Heparin Oligomers.Energetics of myo-inositol hexasulfate binding to human acidic fibroblast growth factor effect of ionic strength and temperature.Arginine Silicate Inositol Complex Accelerates Cutaneous Wound Healing.Bio-Inspired Integration of Natural Materials
P2860
Q24306149-FC79AFB0-9D75-432F-8D8E-B1B27F70FCE7Q26865592-350586FD-B664-4CBE-B127-C21C034D649DQ27469562-503EA7A2-73C2-4D81-B716-D361E0BA3FA9Q27469619-5C0423D2-897F-44C1-8C02-44D35A4D3E6BQ27469695-FC1C5455-1CB1-46A7-B00C-99EB69FA7D73Q27469863-BBEFA381-5C50-4887-9C9E-80CFC26CDF49Q28119211-6BE881DC-D68A-4A0B-A5B6-BC1AFE6C346AQ30816655-A4D41DC8-766B-49C1-B356-AC82D90598CDQ30974717-838FCF89-72FE-4228-8522-51C36D22332DQ33245170-26B05A8C-346B-432B-A696-AC38B5F2D169Q33381618-C935BC4C-D39C-4DC6-9A04-256A903329CEQ33467561-752BF4BC-D19F-44BF-900D-FCBDB698C7DDQ33765731-EDC897C3-BAC4-4ABA-8780-36C5DA2D3AF2Q33965779-29A76F34-E976-4857-A2EA-FB80C6532F13Q34056102-48632A7B-2F30-4368-A874-C2E6027320BBQ35861260-A0667753-6813-42D5-A627-437DB6EF0DA3Q37351931-BB9A25E4-2437-4699-AEED-B12368735872Q37455553-2F922894-3A27-453D-95FB-D068627D2DB1Q37696525-928BDE63-D2F0-473B-9979-4586CA2AD68BQ38307310-D0879889-0317-4864-836D-C164324081FFQ38317243-79863898-C574-4BEA-93E0-C9076D5D6603Q38317756-41D8FEF3-8766-4F86-B2DB-D29938E05C8DQ39572643-AE3CB9B6-36B8-4710-B437-6A8E85D02E48Q39606465-ACD319C3-1591-489D-BD86-C355A23C9A7DQ40116863-1162A6DD-485F-4396-9749-988C40311626Q40999078-CDEBF94D-F98C-4C65-9EBF-B5DF259A2F0EQ41175994-37BE7075-EA93-4684-AA2E-4117D8B19515Q42076709-46B56171-41F7-4A3C-AB5C-63D9E82FA4A1Q42107295-2E869DF5-C7E6-4175-97FB-8AAD46288D70Q43844137-76F8B40F-CB05-4B5C-B872-629D7A9F4166Q44592724-09FA2046-E508-48C4-97C9-78958DAF08A0Q45317193-B5409A3B-3785-4366-9C28-08363427BFD2Q45317195-D84A76CB-2A81-4250-8A6F-1757685017EAQ48224823-02679FA1-811E-4C43-97F8-27CF74EFFFB3Q52077613-44FB2DF7-89F9-4F7B-B236-B11D764BC529Q52844108-704E6F4F-8264-47E1-886E-00787D799147Q57171074-123534E3-68C2-481E-BB1C-131FD170C309
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Heparan sulphate.
@en
type
label
Heparan sulphate.
@en
prefLabel
Heparan sulphate.
@en
P1476
Heparan sulphate.
@en
P2093
Gallagher JT
Stringer SE
P304
P356
10.1016/S1357-2725(96)00170-7
P577
1997-05-01T00:00:00Z